A naukri.com initiative
Bioengineer
3d
132
Image Credit: Bioengineer
How Age, Sex, Hormones, and Genetics Influence Blood-Based Dementia Biomarkers
- A recent study published in Neurology explores how age, sex, hormones, and genetics impact blood-based dementia biomarkers.
- The research, conducted over seventeen years with over a thousand participants, tracked biomarker levels in relation to aging and biological variables.
- Neurofilament light chain proteins, glial acidic proteins, and phosphorylated tau 181 were measured as indicators of neurodegenerative pathology.
- Elevated biomarker levels were associated with increasing age, with older participants showing higher concentrations of these proteins.
- Sex differences were observed, with females having higher glial acidic proteins and males showing elevated neurofilament light chain proteins.
- The APOE ε4 gene variant was linked to increased levels of phosphorylated tau and glial acidic proteins, influencing Alzheimer's risk.
- Hormonal changes, particularly across menopause, were found to affect biomarker trajectories in female participants.
- Monitoring dementia biomarkers in blood could lead to early detection tools for personalized therapeutic strategies.
- While the study provides valuable insights, limitations include a lack of diversity in the participant cohort.
- The findings underscore the importance of a tailored approach considering genetic predispositions and hormonal influences in interpreting biomarkers.
Read Full Article
7 Likes
For uninterrupted reading, download the app